Patents Assigned to Sanzyme Biologics Private Limited
-
Publication number: 20250009815Abstract: Disclosed are compositions for competitive inhibition of pathogens against pathogenic infections comprising (a) Bacillus coagulans; (b) Bacillus subtilis; (c) citric acid; and (d) gallic acid including any combinations thereof. The compositions disclosed in this invention is capable to treat and prevent pathogenic infections of the genital organs as well as suitable for treatment and prevention of dermal infections. A method of preventing recurrence of the infections by way of supporting the growth of inherent natural doderlein microbial populations due to application of the compositions of the present invention are also disclosed. Further, use of the compositions of the present invention obviates the need of prior specific diagnosis of the infections due to its broad-spectrum activity against multiple bacterial and fungal pathogens.Type: ApplicationFiled: September 24, 2024Publication date: January 9, 2025Applicant: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Venkat Swamy Malisetty, Jay Soman
-
Patent number: 12097225Abstract: Disclosed are compositions for competitive inhibition of pathogens against pathogenic infections comprising (a) Bacillus coagulans; (b) Bacillus subtilis; (c) citric acid; and (d) gallic acid including any combinations thereof. The compositions disclosed in this invention is capable to treat and prevent pathogenic infections of the genital organs as well as suitable for treatment and prevention of dermal infections. A method of preventing recurrence of the infections by way of supporting the growth of inherent natural doderlein microbial populations due to application of the compositions of the present invention are also disclosed. Further, use of the compositions of the present invention obviates the need of prior specific diagnosis of the infections due to its broad spectrum activity against multiple bacterial and fungal pathogens.Type: GrantFiled: February 12, 2020Date of Patent: September 24, 2024Assignee: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Venkat Swamy Malisetty, Jay Soman
-
Patent number: 11926847Abstract: Disclosed is a composition for selective enrichment of progressively motile non-fragmented/intact DNA sperms during swim-up of semen sample comprising combination of electrolytes, a mix of excipients, polyyvinylpyrrolidone, recombinant human serum albumin or bovine serum albumin. A method of selective enrichment of DNA-intact sperms using the compositions of the present invention is also disclosed. The DNA fragmentation index of the swim-up sperms are less than the DNA fragmentation index of the neat samples. The media compositions of the present invention are applicable for enrichment of non-fragmented/intact DNA sperms for therapeutic purposes in the field of assisted reproductive technologies.Type: GrantFiled: April 3, 2019Date of Patent: March 12, 2024Assignee: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Jay Soman, Motukuri Mahesh
-
Patent number: 11278578Abstract: Combinations of probiotic compositions are described which are beneficial for human hosts in reducing gas and bloating, stomach acidity, and constipation also capable of boosting the immune capacity. The compositions comprise blends including B. coagulans, B. subtilis, and B. clausii in combination with magnesium stearate, magnesium hydroxide, and simethicone. The combination probiotic compositions of the present invention behave in a synergistic manner in their nature of action both in-vitro and in-vivo. The combination probiotic compositions of the present invention are also very stable for comparatively greater amounts of time period.Type: GrantFiled: August 30, 2019Date of Patent: March 22, 2022Assignee: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Venkat Swamy Malisetty
-
Publication number: 20210155898Abstract: Disclosed is a composition for selective enrichment of progressively motile non-fragmented/intact DNA sperms during swim-up of semen sample comprising combination of electrolytes, a mix of excipients, polyyvinylpyrrolidone, recombinant human serum albumin or bovine serum albumin. A method of selective enrichment of DNA-intact sperms using the compositions of the present invention is also disclosed. The DNA fragmentation index of the swim-up sperms are less than the DNA fragmentation index of the neat samples. The media compositions of the present invention are applicable for enrichment of non-fragmented/intact DNA sperms for therapeutic purposes in the field of assisted reproductive technologies.Type: ApplicationFiled: April 3, 2019Publication date: May 27, 2021Applicant: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Jay Soman, Motukuri Mahesh
-
Publication number: 20200289585Abstract: Disclosed are compositions for competitive inhibition of pathogens against pathogenic infections comprising (a) Bacillus coagulans; (b) Bacillus subtilis; (c) citric acid; and (d) gallic acid including any combinations thereof. The compositions disclosed in this invention is capable to treat and prevent pathogenic infections of the genital organs as well as suitable for treatment and prevention of dermal infections. A method of preventing recurrence of the infections by way of supporting the growth of inherent natural doderlien microbial populations due to application of the compositions of the present invention are also disclosed. Further, use of the compositions of the present invention obviates the need of prior specific diagnosis of the infections due to its broad spectrum activity against multiple bacterial and fungal pathogens.Type: ApplicationFiled: February 12, 2020Publication date: September 17, 2020Applicant: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Venkat Swamy Malisetty, Jay Soman
-
Publication number: 20200069744Abstract: Combinations of probiotic compositions are described which are beneficial for human hosts in reducing gas and bloating, stomach acidity, and constipation also capable of boosting the immune capacity. The compositions comprise blends including B. coagulans, B. subtilis, and B. clausii in combination with magnesium stearate, magnesium hydroxide, and simethicone. The combination probiotic compositions of the present invention behave in a synergistic manner in their nature of action both in-vitro and in-vivo. The combination probiotic compositions of the present invention are also very stable for comparatively greater amounts of time period.Type: ApplicationFiled: August 30, 2019Publication date: March 5, 2020Applicant: Sanzyme Biologics Private LimitedInventors: Raunak Jay Soman, Venkat Swamy Malisetty